Evaluation of clay/poly (l-lactide) microcomposites as anticancer drug, 6-mercaptopurine reservoir through in vitro cytotoxicity, oxidative stress markers and in vivo pharmacokinetics

Colloids and Surfaces B: Biointerfaces

Volumn 112, Issue , 2013, Pages 400-407

  Kevadiya, Bhavesh D ^a,c   Chettiar, Shiva Shankaran ^b   Rajkumar, Shalini ^c   Bajaj, Hari C ^a   Gosai, Kalpeshgiri A ^a   Brahmbhatt, Harshad ^a  

^a CSIR CENTRAL SALT AND MARINE CHEMICALS RESEARCH INSTITUTE   (India)

^b VEER NARMAD SOUTH GUJARAT UNIVERSITY   (India)

^c NIRMA UNIVERSITY   (India)

Author keywords

6 Mercaptopurine; Cytotoxicity; Na+ clay; Neuroblastoma; Oxidative stress

Indexed keywords

6-MERCAPTOPURINE; ANTINEOPLASTIC DRUGS; HUMAN NEUROBLASTOMA; ION-EXCHANGE METHODS; NEUROBLASTOMAS; OXIDATIVE STRESS MARKERS; PARTIAL DIFFUSION; POLY (L-LACTIDE);

CELL CULTURE; COMPOSITE MATERIALS; DRUG PRODUCTS; ENZYME INHIBITION; ION EXCHANGE; OXIDATIVE STRESS; PHARMACOKINETICS; SELF ASSEMBLY;

CYTOTOXICITY;

ANTINEOPLASTIC AGENT; MERCAPTOPURINE; POLYGLACTIN;

ANIMAL EXPERIMENT; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DIFFUSION; DRUG EFFICACY; DRUG RELEASE; FEMALE; IN VITRO STUDY; IN VIVO STUDY; ION EXCHANGE CHROMATOGRAPHY; NEUROBLASTOMA; NEUROBLASTOMA CELL; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; RESERVOIR;

6-MERCAPTOPURINE; CYTOTOXICITY; NA(+)-CLAY; NEUROBLASTOMA; OXIDATIVE STRESS;

6-MERCAPTOPURINE; ALUMINUM SILICATES; ANIMALS; ANTINEOPLASTIC AGENTS; BENTONITE; CELL LINE, TUMOR; CELL SURVIVAL; CHEMISTRY, PHARMACEUTICAL; DOSAGE FORMS; DRUG CARRIERS; FEMALE; HUMANS; LIPID PEROXIDATION; MICROSCOPY, ELECTRON, SCANNING; MICROSPHERES; OXIDATIVE STRESS; POLYESTERS; RATS; RATS, WISTAR; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; X-RAY DIFFRACTION;

EID: 84884197935     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2013.07.008     Document Type: Article

References (44)

1. Law L.W. Proc. Soc. Exp. Biol. Med. 1953, 84:409.
2. Coffey J.J., White C.A., Lesk A.B., Rogers W.I., Serpick A.A. Cancer Res. 1972, 32:1283.
3. Podsiadlo P., Sinani V.A., Bahng J.H., Kam N.W.S., Lee J., Kotov N.A. Langmuir 2008, 24:568.
4. Nielsen O.H., Vainer B. Aliment Pharmacol. Ther. 2001, 15:1699.
5. Nelson J.A., Carpenter J.W., Rose M.L., Adamson D.J. Cancer Res. 1975, 35:2872.
6. Zacchigna M., Cateni F., Di-Luca G., Drioli S. Bioorg. Med. Chem. Lett. 2007, 17:6607.
7. Cheok M.H., Evans W.E. Nat. Rev. Cancer 2006, 6:117.
8. Choi S.J., Choi G.E., Oh J.M., Oh Y.J., Park M.C., Choy J.H. J. Mater. Chem. 2010, 20:9463.
9. Feng S.S., Mei L., Anitha P., Gan C.W., Zhou W. Biomaterials 2009, 30:3297.
10. Kevadiya B.D., Patel T.A., Jhala D.D., Thumbar R.P., Brahmbhatt H., Pandya M.P., Rajkumar S., Joshi G.V., Gadhia P.K., Tripathi C.B., Bajaj H.C. Eur. J. Pharm. Biopharm. 2012, 81:91.
11. Dong Y., Feng S.S. Biomaterials 2005, 26:6068.
12. Kevadiya B.D., Joshi G.V., Bajaj H.C. Int. J. Pharm. 2010, 388:280.
13. Joshi G.V., Patel H.A., Kevadiya B.D., Bajaj H.C. Appl. Clay Sci. 2009, 45:248.
14. Kevadiya B.D., Joshi G.V., Mody H.M., Bajaj H.C. Appl. Clay Sci. 2011, 52:364.
15. Joshi G.V., Kevadiya B.D., Bajaj H.C. Microporous Mesoporous Mater. 2010, 132:526.
16. Umrethia M., Ghosh P.K., Majithya R., Murthy R.S. Cancer Invest. 2007, 25:117.
17. Otsuka M., Matsuda Y., Suwa Y., Fox J.L., Higuchi W.I. J. Pharm. Sci. 1994, 83:1565.
18. Agrawal V., Paul M.K., Mukhopadhyay A.K. J. Liposome Res. 2005, 15:141.
19. Wolinsky J.B., Grinstaff M.W. Adv. Drug Deliv. Rev. 2008, 60:1037.
20. Ramsay J.D.F., Swanton S.W., Bunce J.J. J. Chem. Soc. Faraday Trans. 1999, 86:3919.
21. Szabo T., Mitea R., Leeman H., Premachandra G.S., Johnston C.T., Szekeres M., Dekany I., Schoonheydt R.A. Clays Clay Miner. 2008, 56:494.
22. Joshi G.V., Pawar R.R., Kevadiya B.D., Bajaj H.C. Microporous Mesoporous Mater. 2011, 142:542.
23. Joshi G.V., Kevadiya B.D., Mody H.M., Bajaj H.C. J. Polym. Sci. Part A: Polym. Chem. 2012, 50:423.
24. Joshi G.V., Kevadiya B.D., Patel H.A., Bajaj H.C., Jasra R.V. Int. J. Pharm. 2009, 374:53.
25. Kevadiya B.D., Thumbar R.P., Rajput M.M., Rajkumar S., Brambhatt H., Joshi G.V., Dangi G.P., Mody H.M., Gadhia P.K., Bajaj H.C. Eur. J. Pharm. Sci. 2012, 47:265.
26. Sun B., Ranganathan B., Feng S.S. Biomaterials 2008, 29:475.
27. Depan D., Kumar A.P., Singh R.P. Acta Biomater. 2009, 5:93.
28. Vaiana C.A., Leonard M.K., Drummy L.F., Singh K.M., Bubulya A., Vaia R.A., Naik R.R., Kadakia M.P. Biomacromolecules 2011, 12:3139.
29. Cypes S.H., Saltzman W.M., Giannelis E.P. J. Control. Release 2003, 90:163.
30. Lin F.H., Chen C.H., Cheng W.T.K., Kuo T.F. Biomaterials 2006, 27:3333.
31. Kawase M., Hayashi Y., Kinoshita F., Yamato E., Miyazaki J.I., Yamakawa J., Ishida T., Tamura M., Yagi K. Biol. Pharm. Bull. 2004, 27:2049.
32. Wang X., Du Y., Luo J. Nanotechnology 2008, 19:065707.
33. Katti D.R., Ghosh P., Schmidt S., Katti K.S. Biomacromolecules 2005, 6:3276.
34. Karin S., Christer L. BMC Cancer 2003, 3(10):1471.
35. Mosmann T. J. Immunol. Methods 1983, 65:55.
36. Ohkawa H., Ohishi N., Yagi K. Anal. Biochem. 1979, 95:351.
37. Kakkar P., Das B., Viswanathan P.N. Indian J. Biochem. Biophys. 1984, 4:130.
38. Sedlak J., Lindsay R.H. Anal. Biochem. 1968, 25:192.
39. Levine R.L., Wehr N., Williams J.A., Stadtman E.R., Shacter E. Methods Mol. Biol. 2000, 99:15.
40. Umrethia M.L., Ghosh P.K., Majithiya R.J., Murthy R.S.R. J. Liq. Chromatogr. Relat. Technol. 2006, 29:55.
41. Wolf M.B., Baynes J.W. Biochim. Biophys. Acta 2006, 1760:267.
42. Alexandre J., Nicco C., Chereau C., Alexis Laurent, Weill B., Goldwasser F., Batteux F. J. Natl. Cancer Inst. 2006, 98:236.
43. Conklin K.A. Integr. Cancer Ther. 2004, 3:294.
44. Sun Y., Huang L., Mackenzie G.G., Rigas B. J. Pharmacol. Exp. Ther. 2011, 338:775.